Evidence map›Paper›PMID 35727488›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Correction to: Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation.

Elise Van Breedam, Aleksandra Nijak, Tamariche Buyle-Huybrecht, Julia Di Stefano, Marlies Boeren, Jonas Govaerts, Alessandra Quarta, Tine Swartenbroekx, Eva Z Jacobs, Björn Menten and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Elise Van BreedamLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0002-7471-9064
Aleksandra NijakCardiogenomics Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650, Edegem, Belgium.
Tamariche Buyle-HuybrechtLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0002-2123-8267
Julia Di StefanoLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0003-3825-9803
Marlies BoerenLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0002-7956-6730
Jonas GovaertsLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0003-2688-3158
Alessandra QuartaLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.ORCID 0000-0002-7443-7104
Tine SwartenbroekxLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.
Eva Z JacobsCenter for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent University Hospital, 9000, Ghent, Belgium.
Björn MentenCenter for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent University Hospital, 9000, Ghent, Belgium.
Rik GijsbersLaboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, Faculty of Medicine, KU Leuven, 3000, Leuven, Belgium.
Peter DelputteLaboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, 2610, Wilrijk, Belgium.
Maaike AlaertsCardiogenomics Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650, Edegem, Belgium.
Behrouz HassanniaCenter for Inflammation Research (IRC), VIB-UGent, 9052, Zwijnaarde, Belgium.
Bart LoeysCardiogenomics Group, Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, 2650, Edegem, Belgium.
Zwi BernemanLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium.
Jean-Pierre TimmermansLaboratory of Cell Biology and Histology, University of Antwerp, 2610, Wilrijk, Belgium.
Philippe G JorensLaboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, 2610, Wilrijk, Belgium.
Tom Vanden BergheCenter for Inflammation Research (IRC), VIB-UGent, 9052, Zwijnaarde, Belgium.
Erik FransenStatUa Center for Statistics, University of Antwerp, 2000, Antwerp, Belgium.
An WoutersCenter for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk, Belgium.
Winnok H De VosLaboratory of Cell Biology and Histology, University of Antwerp, 2610, Wilrijk, Belgium.
Peter PonsaertsLaboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610, Wilrijk, Belgium. peter.ponsaerts@uantwerpen.be.ORCID 0000-0002-1892-6499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35727488
PMCPMC9587144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.